4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-22-006282
CHIEF EXECUTIVE OFFICER bought 10,000 shares at $2.32 ($23,200)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2022-09-28 | Purchase | +10,000 | $2.32 | $23,200 | 5,431,873 | D |
| Open-market purchases · 10,000 sh · avg $2.32 · $23,200 | |||||||
Loading xslF345X03/ownership.xml…